Table 1.
Antiproliferative activities of Au(I) complexes against cancer cell lines and inhibition at 5 μM of TrxR activity [104].
| Compounds | Cancer Cells IC50 (μM ± SD) | Non-Cancer Cell BHK21 | TrxR Inhibition (% ± SD) | ||
|---|---|---|---|---|---|
| B16-F10 Melanoma | CT26-WT Colon | 4T1 Breast | |||
| AuPPh3ATT | 5.7 ± 0.5 | 5.7 ± 0.9 | 6.6 ± 0.5 | 18.5 ± 2.9 | 40.7 ± 1.5 |
| AuPEt3ATT | 1.2 ± 0.2 | 1.8 ± 0.8 | 1.6 ± 0.5 | 5.5 ± 0.1 | 51.6 ± 1.6 |
| AuPPh3MOT | 1.8 ± 0.5 | 1.8 ± 0.3 | 3.0 ± 1.8 | 6.9 ± 0.8 | 57.3 ± 0.7 |
| AuPEt3MOT | 1.0 ± 0.1 | 0.9 ± 0.1 | 1.1 ± 0.2 | 5.8 ± 0.1 | 60.2 ± 0.7 |
| AuPPh3Cl | 6.6 ± 0.1 | 12.1 ± 2.8 | 10.3 ± 2.3 | 23.0 ± 0.3 | - |
| AuPEt3Cl | 2.3 ± 0.5 | 9.0 ± 0.7 | 9.5 ± 1.1 | 22.5 ± 0.2 | - |
| AF | 0.5 ± 0.4 | 0.5 ± 0.4 | 0.6 ± 0.2 | 1.6 ± 0.5 | 59.7 ± 1.5 |